Can-Fite Biopharma Ltd (CANF) Q3 2020 Earnings Call

Investor webinar replay

Replay transcript excerpt

quarter results and business update conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Paul Kuntz of Investor Relations. Thank you, sir. You may begin. Thank you. And good morning, everyone, and thanks for joining the CanFight third quarter 2020 conference call. Today, the company will provide a financial update for the quarter ended September 30, 2020, as well as the latest developments in CanFight's advanced stage clinical pipeline. On today's call are CanFight's CEO, Dr. Penina Fishman, and the company's CFO, Monty Farbstein. At the end of the call, we will have a question and answer session. We will start with a brief safe harbor statement. This conference call may contain forward-looking statements about CanFight's expectations, beliefs, or intentions regarding, among other things, market risks and uncertainties, its product development efforts, business financial condition, results of operations, strategies, or prospects. Forward-looking statements can be identified by the use of forward-looking words such as believe, expect, intend, plan, may, should, or anticipate, or other negatives or other variations of these words or other comparable words, or by the fact that these statements do not relate strictly to historical or current matters. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause CanFight's actual results to differ materially from any f...